Search for Stocks /

Shri Ahimsa Naturals FY26: Caffeine Rush Meets Capex Wall

General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.


1. At a Glance

FY26 revenue rose 28.4% to ₹123.32 Cr against FY25’s ₹95.81 Cr, yet the order book tale is a different brew. Net profit jumped 36.8% to ₹30.08 Cr, but capex hammered cash flow: the company burned ₹66.13 Cr on investments and planted ₹70 Cr in a new Sawarda facility expected by March 2027.

Operating margin compressed 300 basis points year-on-year to 29% from 32%, the cost of scaling fast. The market currently prices this at 29x on FY26 earnings, against a peer median of 18.8x. Balance sheet holds ₹43.36 Cr in cash, down sharply from ₹81.32 Cr at year-end FY25.

Is purity in the product paired with prudence in the capex timeline? The data will decide.


2. Introduction

Shri Ahimsa Naturals Limited, incorporated in 1990, extracts natural caffeine from the byproducts of coffee decaffeination and tea processing—a waste-to-wealth model in a niche corner of global FMCG. The company supplies food & beverage, nutraceutical, cosmetic, and pharmaceutical makers with caffeine anhydrous natural and green coffee bean extracts, operating from a single facility in Jaipur, Rajasthan, with certification from ISO 22000, FSSC, WHO-GMP, and Kosher bodies.

The company listed on NSE Emerge in April 2025 and raised fresh capital: ₹50 Cr from the IPO, followed by preferential allotment in January 2026 worth ₹7.57 Cr. The board in May 2026 approved a ₹70 Cr capex envelope—nearly double the company’s market cap—to build out a second facility at Sawarda, Jaipur, targeting a 3x expansion in natural caffeine and green coffee bean extract capacity.

Promoters Nemi Chand Jain and family hold 68.4% as of March 2026, down from 68.68% in March 2025. Two institutional funds hold 1.8% each: Bharat Venture Opportunities Fund and Founders Collective Fund. Public holds 25.35%.


3. Business Model: WTF Do They Even Do?

Shri Ahimsa extracts natural caffeine from crude caffeine—itself a byproduct of global coffee decaffeination plants—and from tea waste. The process yields a 99.9% purity white powder used in energy drinks, pre-workout supplements, and cosmetic products. A single energy drink contains less than 1% caffeine by weight, yet without it, the product is marketing bluster.

Revenue in FY26 broke down: caffeine anhydrous natural contributed ~70% (roughly ₹86 Cr), green coffee bean extract ~27% (₹33 Cr), and crude caffeine and herbal extracts the remainder. The company sells to 50+ customers across 25+ countries; the top customer represents 66% of revenue, the top 5 represent 85%, and the top 10 represent 93.5%. This is a B2B relationship business, not a consumer brand.

The installed capacity stands at 270 MTPA for natural caffeine and 200 MTPA for green coffee bean extract. The Sawarda plant will add 700 MTPA and 500 MTPA respectively, plus 200 MTPA of crude caffeine extraction in-house. The stated strategy: backward integration into decaffeination, forward integration into botanical extracts (ashwagandha, bacopa, curcumin, shilajit), and geographic diversification beyond the US and Europe.

Export revenue was 91% of FY25 sales and 95.24% in FY24. Domestic sales are embryonic. The company claims 97% extraction efficiency, converting a commodity byproduct into a food-grade concentrate at industrial scale—a process built over 30 years of R&D.


4. Financials Overview

Figures are consolidated, in ₹ crore.

Standalone Half-Yearly Results

MetricSep 2024Mar 2025Sep 2025Mar 2026YoY Growth %
Revenue41.055.061.063.014.5
EBITDA14.017.018.018.05.9
PAT10.012.015.015.025.0
EPS5.085.256.366.5023.8

H1 FY26 (Sep 2025 + Mar 2026): revenue reached ₹124 Cr against ₹96 Cr in the same period of FY25, a 29% jump. The most recent half (Mar 2026) recorded revenue of ₹63 Cr, with EBITDA of ₹18 Cr and net profit of ₹15 Cr. Operating margin in H2 FY26 fell to 28% from 30% in H1 FY26, driven by higher employee costs and other expenses.

The business exhibits seasonal lumps: the march half typically carries higher profitability, likely due to order aggregation and customs clearances before

Read Full 16 Point breakdown. Continue reading →
Members get full access to every article.
Become a member
Already a member? Log in
Read Full 16 Point breakdown. Continue reading →